2024 Q2 Form 10-Q Financial Statement

#000106299324010122 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Operating Expenses $114.6K $162.8K
YoY Change -19.99% -23.6%
Operating Profit -$114.6K -$162.8K
YoY Change -19.99% -23.6%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $989.00 -$42.73K
YoY Change -99.49% -70.87%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$113.6K -$205.6K
YoY Change -317.81% -42.87%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 60.86M shares 60.86M shares
Diluted Shares Outstanding 60.86M shares 60.86M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $247.2K $355.4K
YoY Change -77.33% -66.32%
Cash & Equivalents $247.2K $355.4K
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $52.21K $55.55K
YoY Change 49.38% 29.61%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $299.4K $411.0K
YoY Change -73.39% -62.58%
LONG-TERM ASSETS
Property, Plant & Equipment $332.5K $332.5K
YoY Change 14.53% 14.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $344.4K $349.3K
YoY Change 7.14% 7.07%
TOTAL ASSETS
Total Short-Term Assets $299.4K $411.0K
Total Long-Term Assets $344.4K $349.3K
Total Assets $643.8K $760.3K
YoY Change -55.5% -46.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.63K $23.39K
YoY Change -41.5% -63.66%
Accrued Expenses $148.9K $153.9K
YoY Change 8.91% 8.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.279M $1.282M
YoY Change 3.2% 1.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $81.25K $81.25K
YoY Change -14.59% -18.9%
Total Long-Term Liabilities $81.25K $81.25K
YoY Change -14.59% -18.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.279M $1.282M
Total Long-Term Liabilities $81.25K $81.25K
Total Liabilities $1.360M $1.363M
YoY Change 1.94% -0.09%
SHAREHOLDERS EQUITY
Retained Earnings -$7.488M -$7.374M
YoY Change 12.45% 9.88%
Common Stock $60.86K $60.86K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$886.2K -$772.6K
YoY Change
Total Liabilities & Shareholders Equity $643.8K $760.3K
YoY Change -55.5% -46.63%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$113.6K -$205.6K
YoY Change -317.81% -42.87%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities -$108.2K -$200.2K
YoY Change -32.32% -3.99%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $385.0K
YoY Change
Cash From Investing Activities $0.00 $385.0K
YoY Change -3949.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -108.2K -$200.2K
Cash From Investing Activities 0.000 $385.0K
Cash From Financing Activities 0.000
Net Change In Cash -108.2K $184.8K
YoY Change -32.32% -184.58%
FREE CASH FLOW
Cash From Operating Activities -$108.2K -$200.2K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$108.2K -$200.2K
YoY Change -32.32% -8.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
81250 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95544 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
42855 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-205560 usd
CY2024Q1 thmg Proceeds From Deposit On Land Purchase
ProceedsFromDepositOnLandPurchase
0 usd
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6636000 shares
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
384981 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
518223 cad
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Accounting Estimates</span></span></span></p> <p style="margin-left: 18pt; text-align: justify; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions include the carrying value of properties and mineral interests, environmental remediation liabilities, deferred tax assets, and stock-based compensation. Management's estimates and assumptions are based on historical experience and other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></span></p> </div>

Files In Submission

Name View Source Status
0001062993-24-010122-index-headers.html Edgar Link pending
0001062993-24-010122-index.html Edgar Link pending
0001062993-24-010122.txt Edgar Link pending
0001062993-24-010122-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
exhibit95.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
form10qxz002.jpg Edgar Link pending
form10qxz003.jpg Edgar Link pending
form10qxz004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmg-20240331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed
thmg-20240331_pre.xml Edgar Link unprocessable
thmg-20240331_def.xml Edgar Link unprocessable
thmg-20240331_lab.xml Edgar Link unprocessable
thmg-20240331_cal.xml Edgar Link unprocessable